Management of acute atrial fibrillation – Related resources
03.06.2016 • Sonuncu dəyişiklik 19.12.2017
This article is created and updated by the EBMG Editorial Team
Other Evidence summaries
- Amiodarone may be more effective than flecainide in patients with atrial fibrillation who are refractory to type IA antiarrhythmic agents. The impact of amiodarone on mortality remains to be determined .
Clinical guidelines
- Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37(38):2893-2962. Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33(21):2719-47. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31(19):2369-429.
- January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130(23):e199-267.
Literature
- Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, Slotwiner DJ, Scheiner MA, Lerman BB. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000 Mar 21;101(11):1282-7. .
- Lip GY, Tse HF. Management of atrial fibrillation. Lancet 2007 Aug 18;370(9587):604-18.
- Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007 Sep 19;298(11):1312-22.